SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-19-000064
Filing Date
2019-10-01
Accepted
2019-10-01 08:08:53
Documents
11
Period of Report
2019-10-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 30574
2 EXHIBIT 99.1 a191001prs060madslides.htm EX-99.1 17049
3 a191001prs060madslides001.jpg GRAPHIC 127268
4 a191001prs060madslides002.jpg GRAPHIC 123909
5 a191001prs060madslides003.jpg GRAPHIC 152755
6 a191001prs060madslides004.jpg GRAPHIC 151365
7 a191001prs060madslides005.jpg GRAPHIC 134672
8 a191001prs060madslides006.jpg GRAPHIC 152151
9 a191001prs060madslides007.jpg GRAPHIC 63618
10 a191001prs060madslides008.jpg GRAPHIC 119369
11 a191001prs060madslides009.jpg GRAPHIC 77024
  Complete submission text file 0001583648-19-000064.txt   1567218
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 191127587
SIC: 8731 Services-Commercial Physical & Biological Research